| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/29/2004 | EP1003526B1 Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0983300B1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/29/2004 | EP0983080B1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0914146B1 Morphogen treatment for chronic renal failure |
| 09/29/2004 | EP0912196B1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 09/29/2004 | EP0826006B1 Transepithelial transport of molecular species |
| 09/29/2004 | EP0742831B1 Transgenic non-human mammals with progressive neurologic disease |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | EP0627925B1 Trypsin inhibitors |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533283A Use of osteopontin for treatment and/or prevention of neurologic diseases |
| 09/29/2004 | CN1533268A Pharmaceutical composition which comprise solid dispersion of hydroxypropylethyl cellulose phthalate polymer |
| 09/29/2004 | CN1533242A Foot and mouth disease virus vaccine |
| 09/29/2004 | CN1532285A Methanol yeast Pichia pastoris produce the augmenters of liver regeneration and its mutant. |
| 09/29/2004 | CN1532207A Polyethylene glycol derivatives of thymosin alphal |
| 09/29/2004 | CN1532206A Active fragment of thymosin alphal and its polyethylene glycol derivatives |
| 09/29/2004 | CN1531969A Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 09/29/2004 | CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine |
| 09/29/2004 | CN1168739C Narcissus seed glycopeptide and its application |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168498C Child 'xuebao' chewing tablet and preparing process thereof |
| 09/29/2004 | CN1168497C Leptin as an inhibitor of tumor cell proliferation |
| 09/29/2004 | CN1168496C Powder snuff of insulin for administration of lung and its preparing process |
| 09/29/2004 | CN1168495C Modified tumor necrosis factor |
| 09/29/2004 | CN1168494C Injection-type compound bone repairing material containing more biological factors and using animal fibrin as carrier |
| 09/29/2004 | CN1168493C Functional oral preparations |
| 09/29/2004 | CN1168492C Use of activated protein C in porducing medicine and unit formulation containing activated protein C |
| 09/29/2004 | CN1168463C Injection for treating cerebral thrombus and preparation thereof |
| 09/29/2004 | CN1168443C Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors |
| 09/29/2004 | CN1168442C Methods and compsns. for stimulating neurite growth |
| 09/28/2004 | US6797815 A stabilizer for antisense oligonucleotides, enhancing nuclease stability of enzymatic nucleic acid molecules |
| 09/28/2004 | US6797813 AK155 antibodies and binding fragments thereof |
| 09/28/2004 | US6797812 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797808 α-conotoxin peptides |
| 09/28/2004 | US6797807 Compounds and methods for cancer therapy |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797720 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | US6797704 Systemic delivery of compounds through non-invasive bladder administration |
| 09/28/2004 | US6797703 Gene therapy using TGF-β |
| 09/28/2004 | US6797702 Methods and compositions comprising DNA damaging agents and P53 |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797698 Method of treating prolonged critical illness and other conditions having a similar neuroendocrine pattern |
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797695 Human FGF-20 gene and gene expression products |
| 09/28/2004 | US6797693 Methods using PTPase inhibitors and insulin |
| 09/28/2004 | US6797691 With pigment epithelium-derived factor (pedf) |
| 09/28/2004 | US6797513 Nucleic acid encoding CLK2 protein kinases |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797504 For prevention and treatment of cancer, tumors, metastasis; drug screening |
| 09/28/2004 | US6797502 Polypeptide for use in the treatment of hypertriglyceridemia, atherosclerosis and eating disorders |
| 09/28/2004 | US6797501 Protein tyrosine phosphatase PTP20 and related products and methods |
| 09/28/2004 | US6797495 Somatic cells with ablated PrP gene and methods of use |
| 09/28/2004 | US6797494 Containing locus control regions (lcr) from epstein-barr virus; globulins; genetic engineering |
| 09/28/2004 | US6797491 Human papilloma virus treatment |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/28/2004 | US6797483 Polypeptide and DNA thereof |
| 09/28/2004 | US6797473 Methods and compounds for modulating male fertility |
| 09/28/2004 | US6797290 Oral administration of chitosan and glycomacropeptide (gmp), wherein the chitosan and gmp are in other than a cationic gum or polysaccharide/protein complex; cholecystokinin (cck) stimulant; anticholesterol, -lipemic agents |
| 09/28/2004 | US6797289 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 09/28/2004 | US6797287 Administering a formulation containing phaseolamin (white kidney bean extract) and a mineral, such as chromium or vanadium or both for controlling carbohydrate cravings |
| 09/28/2004 | US6797284 Plant extracts and amino acids, that can be used to reduce tobacco smoke addiction |
| 09/28/2004 | US6797273 Neisseria meningitidis antigen |
| 09/28/2004 | US6797271 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 09/28/2004 | US6797270 Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
| 09/28/2004 | US6797269 Mesenchymal stem cells as immunosuppressants |
| 09/28/2004 | US6797266 Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945 |
| 09/28/2004 | US6797265 Therapy for metabolism disorders; gene therapy |
| 09/28/2004 | US6797264 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | US6797258 Compositions and methods for the pulmonary delivery of aerosolized macromolecules |
| 09/28/2004 | US6796429 Transdermal/transmucosal patch packaging |
| 09/28/2004 | CA2458081A1 Peptide antioxidants from soy protein |
| 09/28/2004 | CA2298414C Method for preventing and treating hearing loss using a neurturin protein product |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/26/2004 | CA2424255A1 Immunotoxins |
| 09/24/2004 | WO2005111058A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/24/2004 | CA2517496A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/23/2004 | WO2004081533A2 Vault and vault-like carrier molecules |
| 09/23/2004 | WO2004081229A2 Use of bv8 and/or eg-vegf to promote hematopoiesis |
| 09/23/2004 | WO2004081214A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 09/23/2004 | WO2004081198A2 Methods for modulating angiogenesis with apelin compositions |
| 09/23/2004 | WO2004081195A2 Use of secretin and secretin analogs to treat affective disorders |
| 09/23/2004 | WO2004081190A2 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004081044A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1) |
| 09/23/2004 | WO2004081043A2 Baff mutants with at least one amino acid substitution and methods of their production |
| 09/23/2004 | WO2004081041A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 09/23/2004 | WO2004081040A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |